Obsidian Therapeutics placement
US$350m raised
Announced 14 Apr 2026 · NASDAQ: OBX
Advisers
Obsidian Therapeutics
Issuer
- Legal adviser
- Sidley Austin

Team: Asher Rubin, John Butler, Istvan Hajdu, Alison Lehner, Amanda Chong Artese, Nikita Ponomarev, Emily Chazen, Brendan McCartney, Suzanna Lewis, Sonia Gupta Barros, Katie Klaben, Kayla M. West, Kendell Lee, Demetrius Watson, Tanvi Sharan, Andrea Reed, Vadim Brusser, Torrey Cope, Kevin Sforza, Christian Brause, Greg Featherman, Eric M. Grosshandler, Morgan Ross, Benjamin Nager, Zani Doumbia
Lead managers
- Legal adviser
- Placement agent
- TD Securities (as TD Cowen)
Other advisers
- Legal adviser
- Goodwin

Team: Bill Collins, Tevia Pollard, Gabriela Morales-Rivera, Andrea Akinbola, Timbre Griffin, Keerthi Adusumilli, Madeleine Popp, Claire Treesh, Haylee Brown, Erini Svokos, Katerina Stavrianidis, Steven Tjoe, Krupa Zachariah, Matthew Wetzel, Dustin Schaefer, Tim Worden, Lucy Sharples, Oliver Samuel Walker, Alexandra Denniston, Austin Fahnestock, Timothy Holahan, Brendan Lally-McGurl, Daniel Karelitz, Devan Greevy, Arman Oruc, Simone Waterbury, Jim Matarese, Jonathan Burr, Caroline Bullerjahn, John Barker
- Issuer
- Obsidian Therapeutics
- Issuer based in
- United States
- Completed
- 3 Aug 2026
- Sector
- Biotech
- Tags
- Biotech, Cell Therapy, Oncology
Similar deals
- Chimeric Therapeutics placement (May 2025) May 2025 · US$4.2m · Biotech
- Liminatus Pharma equity raising Feb 2026 · US$4m · Biotech
- Aktis Oncology IPO Jan 2026 · US$318m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
Sources
- 14 Apr 2026 Press release (EX-99.1, exhibit), Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent sec.gov
- 15 Apr 2026 Goodwin Advises Obsidian Therapeutics on Merger With Galera Therapeutics and $350 Million Private Placement Financing goodwinlaw.com
- 21 Apr 2026 Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement Financing sidley.com
- 2 Jul 2026 Definitive merger information statement (DEFM14C), Galera Therapeutics, Inc. sec.gov
- 3 Aug 2026 Press release (EX-99.1, exhibit), Obsidian Therapeutics Completes Closing of Transaction with Galera sec.gov
